Cannabis and Hemp Industry Investment News
The biotechnology company has used its drug delivery system DehydraTECH, to ensure that CBD enters the bloodstream within minutes In various tests, Le...
What are you searching for? viewLexaria Bioscience Corp. The patents, two in the US and two in Australia, bring Lexaria’s total to 15 granted patents,...
Brian Quigley, a 16-year veteren of Lexaria investor Altria Group, is joining the company's board In March, Quigley left Altria to co-found Green Sky ...
The license for the company’s new formulation lab will allow it to produce creams, lotions and focus on delivery of THC and CBD The company said that ...
The company collaborated with the National Research Council of Canada to examine new formulations of Lexaria's delivery platform technology The resear...
What are you searching for? viewLexaria Bioscience Corp. Integra will work with the firm to communicate its message to maximize corporate visibility, ...
What are you searching for? viewLexaria Bioscience Corp. The company has 9 corporate licensees with 11 licenses developing unique products using its a...
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE: LXX) President and CEO Chris Bunka joined Steve Darling from Proacti...
Under the partnership, both Canadian companies will jointly produce Lexaria's DehydraTech products, including THC and CBD powder DehydraTECH masks the...
Novel drug delivery platform DehydraTECH masks unwanted tastes, improves onset speed and increases the bioavailability of active pharmaceutical ingred...
What are you searching for? viewLexaria Bioscience Corp. () Chairman and CEO Chris Bunka joined Steve Darling from Proactive Investors Vancouver on Sk...
The CBD skincare market is projected to bring in US$959 million in sales by 2024 Corporation () announced Tuesday it has signed an agreement with Acti...
Bloch is replacing outgoing director Daryl Fridhandler, who resigned this week () announced that Peter Bloch, the CEO of medical device developer Bres...
The extended agreement comes after positive results following months of tests on InnoCan's CBD-loaded liposomal platform technology -- which allows fo...
The platform enables the targeted injection of hydrogel-cannabinoid-loaded liposomes into the bloodstream or to a specific body part After a few month...
CEO Richard Carleton said the CSE is the go-to exchange for Israeli cannabis companies maximizing access to liquidity Cannabis was the name of the gam...
InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interestin...
Dr Eurico Castro Alves is also the founder of a European business and clinical consultancy offering guidance to the medical cannabis industry EXMceuti...
What are you searching for? viewCanntab Therapeutics Ltd . () CFO Richard Goldstein checked in with Steve Darling from Proactive Investors on Skype to...
The company on Wednesday said it had inked a non-binding Letter of Intent (LOI) with Labsco Promedic SA de CV Canntab is making inroads into Mexico Po...
